2026 NPPES data Epilepsy Physician NPI 1366603730 MD
Verify on CMS →

MUNAZZA SOPHIE, MD

Epilepsy Physician in ALLENTOWN, Pennsylvania. CMS National Plan and Provider Enumeration System profile including specialty classification, practice address, and Medicare prescribing data when reported.

Federal data — no proprietary rating. PlainDoctor publishes the actual CMS NPPES and Medicare records — NPI registration, specialty, practice location, and prescribing data — without a composite score or editorial opinion on top. Every field traces to a federal source.
Prescribing volume
1K
Medicare Part D claims · 267 beneficiaries · Epilepsy Physician avg: 878
Generic prescribing
89%
generic claims · 11% brand-name · higher generic rates reduce patient out-of-pocket costs

What the federal data shows

MUNAZZA SOPHIE, MD filed 1,259 Medicare Part D claims in 2023 as a Epilepsy Physician in ALLENTOWN, Pennsylvania, prescribing 89% generic.

1K
Part D claims, 2023
89%
generic prescribing
Likely
board-certified (heuristic)

Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) — no proprietary rating or editorial opinion is applied.

MUNAZZA SOPHIE, MD's Medicare Part D volume vs every U.S. prescriber

Total Medicare Part D claims, 2023 — across all CMS prescribers nationally

1,259 Top 22% higher than 78% of 1,370,886 prescribers

0–200: 670,926 prescribers (49%). Below this entry. 200–400: 182,923 prescribers (13%). Below this entry. 400–600: 90,619 prescribers (7%). Below this entry. 600–800: 56,224 prescribers (4%). Below this entry. 800–1,000: 40,919 prescribers (3%). Below this entry. 1,000–1,200: 31,827 prescribers (2%). Below this entry. 1,200–1,400: 26,224 prescribers (2%). This entry sits in this band. 1,400–1,600: 21,710 prescribers (2%). Above this entry. 1,600–1,800: 19,072 prescribers (1%). Above this entry. 1,800–2,000: 16,451 prescribers (1%). Above this entry. 2,000–2,200: 213,991 prescribers (16%). Above this entry. This provider 0 2K+ every Part D prescriber (claims/yr), bucketed by value

Each bar is a band; taller bars hold more prescribers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source CMS Medicare Part D Prescriber Public Use File · 2023

Board certification likely (heuristic — not verified)

MUNAZZA SOPHIE, MD practices in an ABMS-board-eligible specialty and shows active CMS Medicare participation + 2 hospital affiliations — signals consistent with board-certified status. For verified board certification, see CertificationMatters.org (the official ABMS public lookup).

What does the federal data show about MUNAZZA SOPHIE, MD?

Quality data not reported

NPI registry status

Active

Issued 06/19/2008

NPI 1366603730

Primary specialty

Epilepsy Physician

Rare

354 US NPIs in this specialty

Medicare Part D claims

1,259 43% vs specialty avg

2023 prescription claims

Specialty avg: 878

Specialty distribution in Pennsylvania

How Epilepsy Physician compares to other specialties among Pennsylvania providers

Pennsylvania providers

Epilepsy Physician share within Pennsylvania

1. Epilepsy Physician42%2. Internal medicine21%3. Family medicine17%4. Surgical12%5. Pediatric8%
Epilepsy Physician share within Pennsylvania

Specialty board-certification context

Estimated specialty board-certified rate — Epilepsy Physician (ABMS / AOA reference)

Quality data not reported
Est. board-certified rate
78%
Epilepsy Physician ABMS/AOA estimate

Est. board-certified rate (Epilepsy Physician) — ABMS / AOA estimate

0%100%78%
Est. board-certified rate (Epilepsy Physician) — ABMS / AOA estimate

The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.

Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).

MUNAZZA SOPHIE, MD appears in the CMS NPPES registry as a Epilepsy Physician provider holding MD credentials at 1250 S CEDAR CREST BLVD STE 405, ALLENTOWN, PA, 18103, with a listed phone of (610) 402-8420. NPI 1366603730 was issued on 06/19/2008. Because NPPES data is self-reported by the provider and refreshed monthly, the address, phone, and specialty reflect what SOPHIE most recently submitted to CMS rather than a vetted directory listing, which is why patients should always confirm the practice is still at this location before scheduling.

Medicare Part D records for calendar year 2023 show 1,259 prescription claims written by this provider, covering 267 Medicare beneficiaries and totaling roughly $554K in drug spend, split 11% brand-name and 89% generic by claim count. These figures capture only Medicare Part D — commercial insurance, Medicaid, and cash-pay prescriptions are not included, and any drug-beneficiary cell under 11 is suppressed by CMS for patient privacy.

Epilepsy Physician is a narrow specialty nationwide, with 354 enrolled providers across 42 states and an average of 878 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline. Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist — always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.

Practice Address

1250 S CEDAR CREST BLVD STE 405
ALLENTOWN, PA 18103

Provider Details

NPI 1366603730
Specialty Epilepsy Physician
Credentials MD
Gender Female
NPI Issued 06/19/2008

Hospital and facility affiliations

Facilities where MUNAZZA SOPHIE, MD bills Medicare from. Star ratings (1-5) are CMS Hospital Compare's "Hospital overall rating" — a composite of mortality, readmission, patient experience, safety, timely care, and efficient use of medical imaging measures. Source: CMS Care Compare.

KEYSTONE REHABILITATION SYSTEMS INC
BIRDSBORO, PA
LEHIGH VALLEY PHYSICIAN GROUP
EASTON, PA

Affiliations sourced from CMS Doctors and Clinicians National Downloadable File; hospital ratings from CMS Hospital General Information dataset (cross-referenced by facility name + state).

License & disciplinary context — Pennsylvania PA-BOM 2023 annual report

Aggregate state board data only — NOT a determination of any individual provider's status. The figures below describe statewide disciplinary activity across all ~45K Pennsylvania medical licensees in 2023 — they are NOT specific to MUNAZZA SOPHIE, MD. To verify MUNAZZA SOPHIE, MD's current license status, search the PA-BOM public license lookup directly, or check the Federation of State Medical Boards (FSMB) verification service.

133
Total board actions, Pennsylvania 2023
Across 129 cases
2.96
Actions per 1,000 licensees
Pennsylvania statewide rate
probation
Most common action type
48 cases

PA-BOM publishes annual disciplinary statistics as part of public-record reporting under each state's Administrative Procedure Act. See the full breakdown by action type and year on the Pennsylvania disciplinary trends page. Cross-checked against FSMB U.S. Medical Regulatory Trends.

Brand vs generic prescribing mix · Typical

MUNAZZA SOPHIE, MD — brand share 11.0%
Specialty average (est.)

11% brand-name claims vs 89% generic, on 1,259 2023 Medicare Part D claims.

The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.

Medicare Part D Prescribing Data

CMS Medicare Part D prescriber-level data for calendar year 2023.

1,259
Total Claims
$554K
Total Drug Cost
267
Medicare Beneficiaries

Prescribing Breakdown

30-Day Fills
2,220
Total Day Supply
65,251
Brand vs Generic
11% brand / 89% generic
Brand Drug Cost
$510K
Generic Drug Cost
$44K

Patient Demographics

Average Patient Age
73.6 years
Avg HCC Risk Score
1.59
Gender Split
45% female / 55% male
Age Distribution
<65: 27, 65-74: 113, 75-84: 101, 85+: 26

Top Prescribed Drugs (Medicare Part D)

Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.

What MUNAZZA SOPHIE, MD prescribes most

Top Medicare Part D drugs by claim count, 2023

claims
Source CMS Medicare Part D Prescriber Public Use File As of 2023
Drug Claims
Carbidopa-Levodopa
Carbidopa/Levodopa
415
Propranolol Hcl
141
Primidone
82
Gabapentin
63
Carbidopa-Levodopa Er
Carbidopa/Levodopa
52
Topiramate
38
Austedo
Deutetrabenazine
30
Pregabalin
27
Ingrezza
Valbenazine Tosylate
25
Propranolol Hcl Er
Propranolol Hcl
23

* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.

Epilepsy Physician Overview

How MUNAZZA SOPHIE, MD fits within the Epilepsy Physician landscape nationally.

354
Epilepsy Physician Providers in US
42
States with Epilepsy Physician
878
Avg Claims per Provider

MUNAZZA SOPHIE, MD's 1,259 claims are above the specialty average of 878.

Nearby Epilepsy Physician Providers in Pennsylvania

Other clinicians with the same primary specialty enrolled in Pennsylvania, drawn from the same CMS NPPES roster as SOPHIE.

Compare Epilepsy Physician nationally: see state-by-state distribution →

Frequently Asked Questions

What is MUNAZZA SOPHIE, MD's specialty?
MUNAZZA SOPHIE, MD specializes in Epilepsy Physician and practices in ALLENTOWN, Pennsylvania. Credentials: MD.
How much does MUNAZZA SOPHIE, MD prescribe under Medicare Part D?
In 2023, MUNAZZA SOPHIE, MD wrote 1,259 Medicare Part D claims totaling $554K in drug costs for 267 beneficiaries.
Where is MUNAZZA SOPHIE, MD located?
MUNAZZA SOPHIE, MD is located at 1250 S CEDAR CREST BLVD STE 405, ALLENTOWN, PA, 18103. Phone: (610) 402-8420.
What is MUNAZZA SOPHIE, MD's NPI number?
MUNAZZA SOPHIE, MD's National Provider Identifier (NPI) is 1366603730, issued on 06/19/2008.
Does MUNAZZA SOPHIE, MD prescribe more brand-name or generic drugs?
MUNAZZA SOPHIE, MD's prescribing is 11% brand-name and 89% generic drugs by claim count, with $510K in brand drug costs.
How many Epilepsy Physician providers are there in the US?
There are 354 Epilepsy Physician providers across 42 states in the US. The average Epilepsy Physician provider writes 878 Medicare Part D claims per year.
What drugs does MUNAZZA SOPHIE, MD prescribe most often?
Based on 2023 Medicare Part D data, MUNAZZA SOPHIE, MD's most frequently prescribed drugs include Carbidopa-Levodopa, Propranolol Hcl, Primidone. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does MUNAZZA SOPHIE, MD accept Medicare?
MUNAZZA SOPHIE, MD appears in CMS Medicare data with 1,259 Part D claims and 267 Medicare beneficiaries in 2023. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify MUNAZZA SOPHIE, MD's credentials?
MUNAZZA SOPHIE, MD's NPI is 1366603730 with credentials MD. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.

Data Sources

Provider Directory
CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
Specialty Classification
NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
Prescribing Data
CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
Limitations
Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.

See our complete data methodology for details on how we collect and process government data.

Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).

Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology